Plain-English translation of NCT07783178 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The EARLY-GLOW study is looking at how blood sugar changes very early in pregnancy—before gestational diabetes is usually diagnosed. Researchers will ask you to wear a special continuous glucose monitor (a small sensor on your arm) for 12 to 16 weeks starting around week 12 of pregnancy. This study compares women who have risk factors for gestational diabetes with women who don't, to see if glucose patterns look different between the two groups.
Gestational diabetes is normally screened for between weeks 24 and 28 of pregnancy, but researchers believe blood sugar problems may start much earlier. By catching these changes earlier with continuous monitoring, doctors hope to identify women at risk sooner and potentially improve outcomes for mother and baby.
You likely qualify if…
You likely don't qualify if…
You will wear a small, blinded continuous glucose monitor (called a Dexcom G7) on your arm for 12 to 16 weeks starting around week 12 of pregnancy. During this time, you won't be able to see your own glucose readings, which helps ensure your behavior isn't influenced by the numbers. You'll also be asked to check your fasting blood sugar at home, take photos of your meals, log what you eat, and answer regular questionnaires about your sleep, stress, physical activity, and how you're feeling. At the end of the study, you may get a second glucose sensor that shows you real-time readings.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Switzerland